Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25488 | 232 | 52.3 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3349 | 1249 | CARRIER ERYTHROCYTES//VASCULAR IMMUNOTARGETING//NANOERYTHROSOMES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASCULAR IMMUNOTARGETING | Author keyword | 20 | 100% | 4% | 9 |
2 | TARGETED THER EUT TRANSLAT NANOMED | Address | 10 | 73% | 3% | 8 |
3 | TRANSLAT TARGETED THER EUT NANOMED | Address | 8 | 75% | 3% | 6 |
4 | MED BIOL SECT ENDOTHELIAL BIOMED VASC DRUG | Address | 6 | 80% | 2% | 4 |
5 | CAM MEDIATED ENDOCYTOSIS | Author keyword | 6 | 100% | 2% | 4 |
6 | ICAM 1 TARGETED NANOCARRIERS | Author keyword | 6 | 100% | 2% | 4 |
7 | TARGETED THER EUT PROGRAM | Address | 3 | 50% | 2% | 5 |
8 | ANTIBODY SURFACE DENSITY | Author keyword | 3 | 100% | 1% | 3 |
9 | POLYMER NANOCARRIERS | Author keyword | 3 | 60% | 1% | 3 |
10 | ENDOTHELIAL TARGETING | Author keyword | 2 | 44% | 2% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYMER NANOCARRIERS | 41 | 81% | 11% | 25 |
2 | ALLEVIATES OXIDATIVE STRESS | 21 | 90% | 4% | 9 |
3 | ICAM 1 TARGETED NANOCARRIERS | 11 | 78% | 3% | 7 |
4 | PULMONARY ENDOTHELIUM | 7 | 33% | 7% | 17 |
5 | SELECTIVE INTRACELLULAR DELIVERY | 6 | 100% | 2% | 4 |
6 | CONJUGATED LIPOSOME | 4 | 75% | 1% | 3 |
7 | E SELECTIN IMMUNOCONJUGATE | 4 | 75% | 1% | 3 |
8 | PROPHYLACTIC THROMBOLYSIS | 2 | 50% | 1% | 3 |
9 | HUMAN PECAM 1 CD31 | 1 | 50% | 1% | 2 |
10 | THERAPEUTIC ENZYMES | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies | 2013 | 14 | 43 | 30% |
Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents | 2014 | 7 | 108 | 26% |
Targeted delivery of therapeutics to endothelium | 2009 | 51 | 160 | 31% |
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm | 2014 | 6 | 345 | 20% |
Advanced drug delivery systems that target the vascular endothelium | 2006 | 66 | 80 | 26% |
Targeted Therapeutics and Nanodevices for Vascular Drug Delivery: Quo Vadis? | 2011 | 1 | 10 | 60% |
Dynamic Factors Controlling Targeting Nanocarriers to Vascular Endothelium | 2012 | 9 | 134 | 25% |
Nanocarriers for vascular delivery of antioxidants | 2011 | 24 | 141 | 17% |
Targeted nanocarriers for imaging and therapy of vascular inflammation | 2011 | 16 | 86 | 20% |
Targeted siRNA Delivery to Diseased Microvascular Endothelial Cells-Cellular and Molecular Concepts | 2011 | 9 | 71 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TARGETED THER EUT TRANSLAT NANOMED | 10 | 73% | 3.4% | 8 |
2 | TRANSLAT TARGETED THER EUT NANOMED | 8 | 75% | 2.6% | 6 |
3 | MED BIOL SECT ENDOTHELIAL BIOMED VASC DRUG | 6 | 80% | 1.7% | 4 |
4 | TARGETED THER EUT PROGRAM | 3 | 50% | 2.2% | 5 |
5 | NANOBIOTECHNOLKITA KU | 2 | 67% | 0.9% | 2 |
6 | NORMAL PATHOL HISTOL CYTOL | 1 | 100% | 0.9% | 2 |
7 | PATHOL MED BIOLMED BIOL SECT | 1 | 40% | 0.9% | 2 |
8 | ENDOTHELIAL BIOMED VASC DRUG TARGETING | 1 | 33% | 0.9% | 2 |
9 | PROGRAM TARGETED THER EUT | 1 | 33% | 0.9% | 2 |
10 | U479 PHAGOCYTES REPONSES INFLAMMATOI | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179324 | CAROLINA CANC NANOTECHNOL EXCELLENCE//ARTIFICIAL ANTIGEN PRESENTING CELL//SLOAN KETTERING CANC |
2 | 0.0000145890 | CATCH BONDS//BELL MODEL//CELL ROLLING |
3 | 0.0000122395 | PECAM 1//JAM A//JUNCTIONAL ADHESION MOLECULE A |
4 | 0.0000111009 | CARRIER ERYTHROCYTES//NANOERYTHROSOMES//HYPOTONIC DIALYSIS |
5 | 0.0000098106 | CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE |
6 | 0.0000088547 | INTRA ARTICULAR DRUG DELIVERY//PARENTERAL DEPOTS//ROTATING DIALYSIS CELL |
7 | 0.0000086583 | LIPOSOME//THERMOSENSITIVE LIPOSOMES//IMMUNOLIPOSOMES |
8 | 0.0000069274 | ENDOGENOUS ANTIOXIDANT DEFENCE//MELON EXTRACT//ORGOTEIN |
9 | 0.0000069116 | GS NITROXIDE//LECITHINIZED SUPEROXIDE DISMUTASE//P INFECT ONCOL |
10 | 0.0000067723 | BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2 |